Methi
Trigonella foenum-graecum
Methi (Trigonella foenum-graecum) is a plant drug, also called Methika, Dipani and Methini. WHO published monograph on fenugreek seeds (Semen Trigonellae Foenugraeci) in WHO Monographs on Selected Medicinal Plants, Volume 3 (2007).
| Botanical name | Trigonella foenum-graecum |
|---|---|
| Family | Fabaceae · other entries in this family |
| Order | Fabales |
| Pharmacopoeia status | WHO published monograph on fenugreek seeds (Semen Trigonellae Foenugraeci) in WHO Monographs on Selected Medicinal Plants, Volume 3 (2007). European Medicines Agency (EMA) published European Union herbal monograph with Revision 1 for traditional use. Authorized as single active substance in France, Poland, and Spain. ESCOP monograph recommends 25 g powdered seeds daily for diabetes/hypercholesterolaemia adjuvant therapy, and 1-6 g for appetite stimulation. Listed in NCCIH (US National Center for Complementary and Integrative Health) database. Included in Indian Pharmacopoeia and Ayurvedic Pharmacopoeia of India. One of the most comprehensively documented Ayurvedic herbs in Western regulatory frameworks. |
| Taxon identifiers | GBIF 5360475 · Wikidata Q133205 · NCBI Taxonomy 78534 |
| Sanskrit | मेथिका (methikā), दीपनी (dīpanī), मेथिनी (methinī) |
|---|---|
| Hindi | मेथी (methī) |
| Tamil | வெந்தயம் |
Sources: Ayurvedic Pharmacopoeia of India, METHI (Seed) monograph on Trigonella foenum-graecum, Hindi "Methi"; MMPND Trigonella page, Hindi line "कसूरी मेथी Kasoorii methii (leaves-dried), मेंथी Methi (seeds), मेथि Methi (seeds), मोटी सौंफ़ Motee saunf".; Ayurvedic Pharmacopoeia of India, METHI (Seed) monograph, Sanskrit "Methini"; Rājanighaṇṭu 6.67-69 (via wisdomlib), second synonym "Methinī".; Ayurvedic Pharmacopoeia of India, METHI monograph, Tamil "Mendium, Ventaiyam"; MMPND Trigonella page, Tamil line "Mathai, மேதி Meti, Uluvaarisi, Vendayum, வெந்தியம் Ventayam, வெந்தய கீரை Ventaya kirai".; Rājanighaṇṭu (13th c.) 6.67-69, as transcribed on wisdomlib's Methi entry, which lists 16 synonyms of Methī: "Methikā, Methinī, Dīpanī, Bahupatrikā, Vedhanī, Gandhavījā, Jyoti, Gandhaphālā, Vallarī, Candrikā, Methā, Miśrapuṣpā, Kairavī, Kuñcikā, Pītavījā and Bahuparṇī."; Rājanighaṇṭu 6.67-69 (via wisdomlib), where Methikā is the first of the 16 listed synonyms; MMPND Trigonella page, Sanskrit line "Chandrika, गंधबीजा Gandhabiijaa, Kairava, Medhika, Methika, Sarapunkha".. How we source.
The evidence at a glance
12papers on this site for this drug, published 2012 to 2026, 11 with a DOI.
- 2Systematic reviews and meta-analyses
- 2Randomised controlled trials
- 8Other clinical studies and reviews
A count is not a conclusion and a tier is a study design, not a verdict. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.
Names and identification
| Language | Name |
|---|---|
| English | Methi |
How does it work?
- 4-Hydroxyisoleucine (4-OHIle): Non-protein amino acid that increases glucose-induced insulin release in a glucose-concentration-dependent manner; stimulates glucose uptake by increasing surface GLUT4 via PI3K-dependent pathway in skeletal muscle.
- 4-OHIle anti-inflammatory: Ameliorates fatty acid-induced insulin resistance and inflammatory response in skeletal muscle cells.
- Diosgenin: Steroidal sapogenin serving as pharmaceutical precursor; inhibits aberrant crypt foci formation and induces apoptosis in colon cancer cells; anti-hypercholesterolemic and anti-inflammatory effects.
- Trigonelline: Alkaloid contributing to antidiabetic properties through multiple pathways.
- Soluble fiber (galactomannan): High fiber content slows gastric emptying and glucose absorption, contributing to glycemic control.
- Multi-tissue targeting: Pancreas (insulin secretion), skeletal muscle (glucose uptake via GLUT4), liver (gluconeogenesis reduction), adipose tissue (lipid metabolism), and gut (glucose absorption) are all modulated.
- Hormonal modulation: Influences testosterone levels and reproductive hormones.
Modern Research (Meta-Analysis)
Total PubMed publications found: 1948
Key Research Papers
1. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion.
Authors: Nagulapalli Venkata Kalyan C, Swaroop Anand, Bagchi Debasis et al. Journal: Molecular nutrition & food research (2017) PMID: 28266134
Plant-derived natural products have long-standing utility toward treating degenerative diseases. It is estimated that about two-thirds of world population depend on traditional medicine for primary medical needs. Fenugreek (Trigonella foenum-graecum Linn.), a short-living annual medicinal plant belonging to Fabaceae family, is used extensively in various parts of the world as herb, food, spice, and traditional medicine. Fenugreek is considered as one of the oldest medicinal plants and its health-promoting effects have been cited in Ayurveda and traditional Chinese medicine. The investigations into the chemical composition and pharmacological actions have seen a renaissance in recent years. Extensive preclinical and clinical research have outlined the pharmaceutical uses of fenugreek as ant…
Keywords: Cancer, Diabetes, Health benefits, Phytochemicals, Trigonella foenum-graecum
2. Effects of
Authors: Faghfoori Zeinab, Javadivala Zeinab, Khalili Yeganeh et al. Journal: Immunopharmacology and immunotoxicology (2023) PMID: 37039783
Adjuvant therapies especially medicinal plants have gained lots of attention nowadays and have been consumed all over the world for treating different diseases particularly rheumatoid arthritis (RA). Recent animal studies have indicated the benefits of fenugreek in RA and indicate that it may be a therapeutic candidate in RA; nonetheless, no systematic review is available about fenugreek and RA. This paper systematically reviewed the existing studies about fenugreek and RA and plausible mechanisms…
Keywords: Trigonella, arthritis, rheumatoid, systematic review
3. Antidiabetic potential of fenugreek (
Authors: Sarker Dipto Kumer, Ray Pallobi, Dutta Ashit Kumar et al. Journal: Food science & nutrition (2024) PMID: 39479631
Fenugreek (…
Keywords: Trigonella foenum‐graecum, bioactive compounds, diabetes, fenugreek, molecular mechanism
4. Toxicological properties of fenugreek (Trigonella foenum graecum).
Authors: Ouzir Mounir, El Bairi Khalid, Amzazi Saaïd Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2016) PMID: 27498339
Fenugreek (Trigonella foenum graecum), used as traditional medicine and natural additive food, has been shown to exert significant antiatherogenic, antidiabetic, antianorexic, antioxidant, anticarcinogenic, antihyperlipidemic, galactogogue and anti-inflammatory effects in several human and animal models. Besides, several medicinal pharmaceutical and nutraceutical properties, fenugreek have toxic effects as well. The aim of this review is discuss the cumulative evidence, which suggests that consumption of fenugreek induced some serious toxicological side effects. In this review, many teratogenic effects of fenugreek, from congenital malformations to death, were reported in human, rodent, rabbit, and chick. Moreover, results obtained in rats, mice and rabbits show a testicular toxicity and a…
Keywords: Allergenicity, Anti-fertility effect, Antigenicity, Clinical toxicity, Fenugreek, Genotoxicity, LD50, Neurotoxicity, Teratogenicity, Toxicity
5. Trigonella foenum-graecum (fenugreek) differentially regulates antioxidant potential, photosynthetic, and metabolic activities under arsenic stress.
Authors: Ahmad Javed, Beg Md Amjad, Ali Arlene A et al. Journal: Ecotoxicology and environmental safety (2022) PMID: 36193587
Arsenic (As) contamination is continuously increasing in the groundwaters and soils around the world causing toxicity in the plants with a detrimental effect on physiology, growth, and yield. In a hydroponic system, thirty-day-old plants of Trigonella foenum-graecum were subjected to 0, 50, or 100 µM NaHAsO…
Keywords: Antioxidant capacity, GC-MS, Hill reaction activity, Metabolites, Oxidative stress, Trigonella foenum-graecum
6. Revisiting
Authors: Visuvanathan Theysshana, Than Leslie Thian Lung, Stanslas Johnson et al. Journal: Plants (Basel, Switzerland) (2022) PMID: 35684222
Fenugreek (…
Keywords: alkaloids, fenugreek, pharmacological potential, phytochemicals, saponins, trigonella foenum-graecum
7. 4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity.
Authors: Avalos-Soriano Anaguiven, De la Cruz-Cordero Ricardo, Rosado Jorge L et al. Journal: Molecules (Basel, Switzerland) (2016) PMID: 27879673
Obesity and insulin resistance (IR) are interdependent multifactorial processes that cannot be understood separately. Obesity leads to systemic inflammation and increased levels of free fatty acids that provoke IR and lipotoxicity. At the same time, IR exacerbates adipose cell dysfunction, resulting in chronic inflammation and major lipotoxic effects on nonadipose tissues. 4-Hydroxyisoleucine (4-OHIle), a peculiar nonprotein amino acid isolated from fenugreek (…
Keywords: 4-hydroxyisoleucine, Trigonella foenum-graecum, fenugreek, insulinotropic
8. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials.
Authors: Neelakantan Nithya, Narayanan Madanagopal, de Souza Russell J et al. Journal: Nutrition journal (2014) PMID: 24438170
Fenugreek is a herb that is widely used in cooking and as a traditional medicine for diabetes in Asia. It has been shown to acutely lower postprandial glucose levels, but the long-term effect on glycemia remains uncertain. We systematically reviewed clinical trials of the effect of fenugreek intake on markers of glucose homeostasis…
What do recent studies show?
- Fakhr L, Chehregosha F, Zarezadeh M and others 2023. Effects of fenugreek supplementation on the components of metabolic syndrome: A systematic review and dose-response meta-analysis of randomized clinical trials. Pharmacological research. PMID 36470549 · doi:10.1016/j.phrs.2022.106594
Dose-response meta-analysis demonstrated beneficial effects of fenugreek supplementation on multiple metabolic syndrome components including glycemic and lipid parameters in randomized clinical trials. - Kim J, Noh W, Kim A and others 2023. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International journal of molecular sciences. PMID 37762302 · doi:10.3390/ijms241813999
Systematic review and meta-analysis confirmed beneficial effects on glycemic control parameters and lipid profiles in T2DM, supporting fenugreek as complementary diabetes therapy. - Amiri Ardekani E, Parvizi MM, Zare R and others 2026. Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review. Iranian journal of medical sciences. PMID 41625343 · doi:10.30476/ijms.2025.106073.4017
Scoping review of 60 articles (Jan 1990-Sep 2024): 14 clinical trials reported adverse effects, 23 reported none, 13 did not report. Most common adverse effect was mild gastrointestinal discomfort. No fatalities attributed to fenugreek use. - Vajdi M, Noshadi N, Bonyadian A and others 2024. Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Heliyon. PMID 39286181 · doi:10.1016/j.heliyon.2024.e36649
Meta-analysis confirmed therapeutic benefit of fenugreek supplementation for T2DM management, with significant improvements in glycemic markers.
Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Most common adverse effect: mild gastrointestinal discomfort (stomach upset, diarrhea, bloating) following oral consumption.
- Hypoglycemia risk: Due to possible hypoglycaemic effect, close monitoring of glycaemic control recommended in diabetic patients (EMA monograph warning).
- Allergic reactions: 10 case reports/series documented allergic reactions or hypersensitivity (cross-reactivity possible with chickpeas and other legumes).
- Maple syrup odor: Characteristic odor in sweat, urine, or skin of mothers and breastfed infants — can mimic maple syrup urine disease in neonatal screening.
- Suspected hypokalemia reported in some cases.
- Pregnancy contraindicated: Not recommended during pregnancy due to potential uterotonic effects.
- Few drug interactions documented; caution with diabetes, asthma, and potassium-lowering medications.
- Hepatotoxicity: No clinically apparent liver injury cases attributed to fenugreek alone despite widespread use; prospective studies show no effect on serum enzyme levels at therapeutic doses.
- Case report (2025): Ribociclib-induced hepatotoxicity potentially exacerbated by concurrent fenugreek supplement use, suggesting possible CYP-mediated interactions with oncology drugs.
- No fatalities attributed to fenugreek use in the literature.
What is it made of?
The marker compounds are listed under Dosage forms and preparation, below.
Dosage forms and preparation
Dosage Forms: Churna (seed powder), Capsules, Tablets, Decoction, Sprouted seeds, Extract (hydroalcoholic), Mucilage gel, Topical paste/hair mask
Standard Dosage: 5-30 g seed powder per day; 500-1000 mg standardized extract twice daily; 5-10 g soaked/sprouted seeds daily
Optimal Timing: 30 minutes before meals for glycemic control (fiber and 4-hydroxyisoleucine need time to form gel); soaked seeds in morning for general health; topical paste overnight for hair health
Storage: Whole seeds in cool, dry conditions at room temperature. Ground powder in airtight containers below 25 deg C. Extract capsules in blister packs with desiccant. Mucilage gel refrigerated at 2-8 deg C after opening.
Marker Compounds: 4-Hydroxyisoleucine, Diosgenin, Trigonelline, Galactomannan, Sotolon, Yamogenin, Gitogenin, Protodioscin
Synergistic Combinations
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Systematic reviews and meta-analyses2
- 2023. Effects of fenugreek supplementation on the components of metabolic syndrome: A systematic review and dose-response meta-analysis of randomized clinical trialsPharmacological research. PMID 36470549 · doi:10.1016/j.phrs.2022.106594
- 2023. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsInternational journal of molecular sciences. PMID 37762302 · doi:10.3390/ijms241813999
Randomised controlled trials2
- 2019. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the kneePhytotherapy research : PTR. PMID 30838706 · doi:10.1002/ptr.6338
- 2016. Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical studyThe aging male : the official journal of the International Society for the Study of the Aging Male. PMID 26791805 · doi:10.3109/13685538.2015.1135323
Other clinical studies and reviews8
- 2026. Exploring the Adverse Effects of Fenugreek in Humans: A Scoping ReviewIranian journal of medical sciences. PMID 41625343 · doi:10.30476/ijms.2025.106073.4017
- 2025. Bioactive Potential and Health Benefits of Trigonella foenum-graecum L.: A Comprehensive ReviewFood science & nutrition. PMID 40918167 · doi:10.1002/fsn3.70887
- 2025. Withania somnifera and Trigonella foenum-graecum as ingredients of testosterone-boosting supplements: Possible clinical implicationsAdvances in clinical and experimental medicine : official organ Wroclaw Medical University. PMID 38628109 · doi:10.17219/acem/185743
- 2022. Revisiting Trigonella foenum-graecum L.: Pharmacology and Therapeutic PotentialitiesPlants (Basel, Switzerland). PMID 35684222 · doi:10.3390/plants11111450
- 2016. A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L)Journal of evidence-based complementary & alternative medicine. PMID 25922446 · doi:10.1177/2156587215583405
- 2016. Toxicological properties of fenugreek (Trigonella foenum graecum)Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. PMID 27498339 · doi:10.1016/j.fct.2016.08.003
- 2014. Pharmacological effects of Trigonella foenum-graecum L. in health and diseasePharmaceutical biology. PMID 24102093 · doi:10.3109/13880209.2013.826247
- 2012. Fenugreek PMID 31644133
Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.